Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 285 is a human protein encoded by the ZNF285 gene located on chromosome 19 and is part of the large zinc finger protein family, which is characterized by the presence of zinc finger motifs that facilitate binding to DNA. The primary role of this protein family is the regulation of gene transcription, often by interacting with specific DNA sequences via C2H2-type zinc finger domains. While zinc finger proteins are widespread and critical for various cellular functions, Zinc finger protein 285 itself is primarily classified as a putative transcription factor with limited direct disease association or therapeutic targeting evidence. The gene encoding this protein (ZNF285) has several transcript variants and multiple orthologues/paralogues, typical of zinc finger protein genes. Aliases such as ZNF285A are used interchangeably in genomic and proteomic databases. No evidence has been found in current literature or large biomedical databases to suggest ZNF285 is a direct therapeutic target, nor are there drugs targeting this molecule, known disease biomarkers, or established safety/therapeutic concerns related specifically to this molecule. ZNF285 should not be confused with pseudogenes such as ZNF285CP, which are non-functional copies. Zinc finger proteins primarily act as transcription factors, modulating gene expression by binding to DNA, sometimes also protein or RNA, depending on the context and domain structure. No published disease roles are assigned specifically to ZNF285 as of the latest gene/protein annotations; thus "disease_roles," "interacting_drugs," "mechanism_of_action," "biomarkers," and "safety_concerns" are null for this entry. The current evidence is consistent with a role as a generic transcriptional regulator with no direct therapeutic relevance at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 285 (ZNF285).